PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28098196-1	2017	Hydrous ferric oxide (HFO) is most effective with high treatment capacity on arsenate [As(V)] sorption although its transformation and aggregation nature need further improvement.	ferric oxide	8-20	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	87-92	
28098196-1	2017	Hydrous ferric oxide (HFO) is most effective with high treatment capacity on arsenate [As(V)] sorption although its transformation and aggregation nature need further improvement.	ferric oxide	22-25	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	87-92	
28098196-2	2017	Here, HFO nanoparticles with carboxymethyl cellulose (CMC) or starch as modifier was synthesized for the purpose of stability improvement and As(V) removal from water.	ferric oxide	6-9	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	142-147	
28098196-4	2017	The large-pore structure, high surface specific area, and the non-aggregated nature of CMC-HFO lead to increased adsorption sites, and thus high adsorption capacities of As(V) without pre-treatment (355 mg g-1), which is much greater than those reported in previous studies.	ferric oxide	91-94	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	170-175	
28098196-6	2017	FTIR, XPS and XRD analyses suggested that precipitation and surface complexation were primary mechanisms for As(V) removal by CMC modified HFO nanoparticles.	ferric oxide	139-142	SRC proto-oncogene, non-receptor tyrosine kinase	Homo sapiens	109-114